Navigation Links
UAB study examines hearing loss, Viagra use
Date:5/18/2010

BIRMINGHAM, Ala. Research by a University of Alabama at Birmingham (UAB) professor shows an association between hearing loss and the use of the erectile dysfunction drug Viagra.

Findings published May 18 in Archives of Otolaryngology-Head and Neck Surgery indicate a potential for long-term hearing loss following use of Viagra, and possibly following use of other phosphodiesterase type 5 inhibitors (PDE-5i) drugs such as Cialis and Levitra, although results on those drugs are inconclusive.

"It appears from these findings that the current government warning regarding hearing loss and the use of PDE-5i medications is warranted," said study author Gerald McGwin, Ph.D., a professor of epidemiology in the UAB School of Public Health. "Though there are limitations to this study, it is prudent that patients using these medications be warned about the signs and symptoms of hearing impairment and be encouraged to seek immediate medical attention to potentially forestall permanent damage."

In 2007, following the report of several case studies potentially linking PDE-5i use and sudden hearing loss, the Food and Drug Administration announced labeling changes for PDE-5i medications so that the risk of hearing problems was more prominently displayed. McGwin said this is the first epidemiologic study to evaluate the relationship between PDE-5i drugs and long-term hearing loss.

McGwin examined data on 11,525 men over 40 years of age gathered by the Medical Expenditure Panel Survey, a survey conducted by the federal Agency for Healthcare Research and Quality between 2003 and 2006. Men who reported use of PDE-5i medications were twice as likely to also report hearing loss as were men who had not used the drugs.

McGwin said the relationship was strongest for men reporting use of sildenafil (Viagra) over those who used tadalafil (Cialis) or vardenafil (Levitra), a finding he attributed in part to a small sample size for both o
'/>"/>

Contact: Bob Shepard
bshep@uab.edu
205-934-8934
University of Alabama at Birmingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study finds 2 sling surgeries equally effective for bladder control in women
2. Newborn infants learn while asleep; study may lead to later disability tests
3. Worlds biggest study on cell phones and brain cancer inconclusive
4. Varicose vein study shows radiofrequency ablation causes less post-operative pain
5. Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved
6. Lifestyle factors significantly impact survival of non-Hodgkins lymphoma patients, study finds
7. Study identifies 1 of the mechanisms behind breast cancer metastasis
8. Study shows costs and benefits of testosterone in birds
9. Study finds rotavirus vaccine greatly reduces hospitalizations for acute gastroenteritis in children
10. Childhood psychological problems create long-term economic losses, study finds
11. HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- Genetic fragments of the ... barn where an infected camel was kept, a new study ... to determine if Middle East Respiratory Syndrome (MERS) can be ... air samples over three consecutive days from a camel barn ... of the town of Jeddah, Saudi Arabia. The man later ...
(Date:7/22/2014)... electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), ... Like antidepressant medications, however, they typically have a ... several weeks of regular ECT treatments before a ... an impetus to develop antidepressant treatments that act ... (LFMS) is one such potential new treatment with ...
(Date:7/22/2014)... The “Human Insulin Market by Product ... Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], ... Others) - Forecast to 2019” provides a detailed ... current market trends, and strategies impacting the global ... forecasts of the revenue and share analysis. , ...
(Date:7/22/2014)... Cloud+MD Office 2.0 is a ... medical software and services, designed by experienced healthcare ... “Actionable Information” to help Independent Physician Practices, New ... Services optimize a wide range of business processes ... Noticeable Cost Reductions and Better Patient Care. ...
(Date:7/22/2014)... 2014 For the past nine years, ... been working in tandem to help thousands of cancer ... to care, and help survivors connect to resources dealing ... expanded their partnership to include referrals from PAF to ... the other practical, emotional, and financial issues that accompany ...
Breaking Medicine News(10 mins):Health News:MERS Virus Found in Air in Camel Barn 2Health News:Low strength brain stimulation may be effective for depression 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Cloud-MD Software will soon Receive MU2 Certification 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3
... and NEW YORK, Feb. 11 ActivCore ... exclusive distributor of Redcord,products in the United ... with,Wellness in Motion (WIM). ActivCore will ... Training Network that will serve,therapy professionals, chiropractors, ...
... to Make Women,s Concerns Central to National Health ... Stabenow (D-MI), House Democratic Co-Chair of the Congressional ... other Congressional leaders introduced a resolution today that ... will make women,s needs a key part of ...
... announces FDA 510(k) Class,II clearance for the world,s ... respiration rates, bed occupancy and,movement. Under the brand ... device in the US and Canada under an ... 2000 received the sign off from,the FDA,s Division ...
... Demonstrates That Small Gains in Member Retention ... Market research conducted on behalf of ... can significantly improve revenue generation by establishing ... host of economic factors are currently driving ...
... (NYSE: HRC ) invites you to listen ... Investor Relations, Communications and Global Brand,Development, Hill-Rom. He ... in Las Vegas on Tuesday, February 24, 2009, at,9:40 ... invited to listen to the live audio-only webcast via ...
... through Associate Giving CampaignDENVER, Feb. 11 Anthem ... a long history of giving back to the ... 2008, the strong commitment continued through financial support ... Foundation and the generosity of the company,s associates.Anthem,s ...
Cached Medicine News:Health News:ActivCore LLC Announces Strategic Partnership with Wellness in Motion 2Health News:Congressional Leaders, Public Health Experts Announce New Framework to Promote Women's Health 2Health News:Congressional Leaders, Public Health Experts Announce New Framework to Promote Women's Health 3Health News:Sensiotec Announces FDA 510(k) Class II Clearance for the World's First UWB Healthcare Unbound, Wireless, Non-Contact, Vital Signs and Movement Monitor 2Health News:Lowering Health Insurance Member Disenrollment Can Generate up to $100 Million in Incremental Revenue for Health Plans 2Health News:Lowering Health Insurance Member Disenrollment Can Generate up to $100 Million in Incremental Revenue for Health Plans 3Health News:Anthem Blue Cross and Blue Shield in Colorado and its Foundation Commit $1.6 Million in 2008 2Health News:Anthem Blue Cross and Blue Shield in Colorado and its Foundation Commit $1.6 Million in 2008 3Health News:Anthem Blue Cross and Blue Shield in Colorado and its Foundation Commit $1.6 Million in 2008 4
(Date:7/21/2014)... July 21, 2014  Champions Oncology (OTC: CSBR), a ... and services to personalize the development and use of ... and operational results for the fourth quarter and fiscal ... 2014, after market close. The company will ... day at 4:30 p.m. EDT (1:30 p.m. PDT). To ...
(Date:7/21/2014)... NEW YORK , July 21, 2014  EHE ... physical exams with a nationwide physician network, today announced ... Las Vegas, NV has been named ... in the Las Vegas region ... to help proactively maintain their health. ...
(Date:7/21/2014)... 21, 2014 ... "Global biosimilars/follow-on-biologics market (types, applications and geography) - ... Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 ... would reach $35 billion by 2020 from the ... clearer regulatory pathways in developed markets and higher ...
Breaking Medicine Technology:EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 2Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 3Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 4
... Infection Prevention Professionals With Guidelines,and Tools, ... Association for,Professionals in Infection Control and ... new educational initiatives aimed at eliminating,healthcare-associated ... and the three infections that the ...
... Innocoll, Inc., a privately-held,specialty pharmaceutical company, announced ... clinical trials sponsored by its wholly owned ... TOPICAL for the,treatment and prevention of infected ... GENTAMICIN TOPICAL is a biodegradable and fully ...
Cached Medicine Technology:APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS 2APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 4
Dnase-free, with an integral filter to protect against carry over and contamination from aerosols...
... TowerPack is an innovative, quick and ... Tips. Use 60% less space on ... plastic. With this amazingly easy-to-use, one-hand ... for the whole range of Diamond ...
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes. Can also be used with 20, 25, 50, 100 and 200 L pipette...
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
Medicine Products: